Concepedia

Christopher J. Herrem

CJ

3

Publications

266

Citations

3

H-Index

2003

Active since

Affiliations

University of Pittsburgh(Current)

UPMC Hillman Cancer Center

The University of Osaka

Cleveland Clinic

Christopher J. Herrem is an author at University of Pittsburgh specializing in immunology, tumor microenvironment, and tumor biology.

Top concepts

Publications per year

2003–2008

3

Publications

3

Disease stage variation in CD4+ and CD8+ T-cell reactivity to the receptor tyrosine kinase EphA2 in patients with renal cell carcinoma.

Tomohide Tatsumi, Christopher J. Herrem, Walter C. Olson et al. · PubMed · 2003 · 141 citations

, , +21

Expression of EphA2 is Prognostic of Disease-Free Interval and Overall Survival in Surgically Treated Patients with Renal Cell Carcinoma

Christopher J. Herrem, Tomohide Tatsumi, Kathleen S. Olson et al. · Clinical Cancer Research · 2005 · 98 citations · Full text

Enhancement in Specific CD8+ T Cell Recognition of EphA2+ Tumors In Vitro and In Vivo after Treatment with Ligand Agonists

Amy Wesa, Christopher J. Herrem, Maja Mandić et al. · The Journal of Immunology · 2008 · 27 citations · Full text

, , +15

Rows per page

1–3 of 3